PECAM1 and cancer: Analysis of the endothelial marker CD31 in metastatic nodules at week 1, 2 or 3 post cancer cell injection revealed that, although early nodules (week 1 or 2) grew in proximity to blood vessels, the presence of vessels within metastatic nodules was primarily observed at a later stage (week 3) (Fig. 1a–c).